Picture of International Biotechnology Trust logo

IBT — International Biotechnology Trust News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsBalancedSmall Cap

RCS - Intnl. Biotechnology - Latest Factsheet and Blog

RNS Number : 0388K

Intl. Biotechnology Trust PLC

27 May 2025

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC ("IBT")

 

Latest Factsheet and Blog

 

 

IBT's factsheet for the month ended 30 April 2025 is now available directly via its web page. Please click here, then 'latest factsheet'.

 

Successful biotech investing isn't just about spotting winners - it's also about filtering out the likely failures. From dubious clinical data to overconfident founders, Ailsa Craig and Marek Poszepczynski, IBTs Portfolio Managers, have seen it all. In their latest blog post, they take a look at what to expect, with help from the history books.

 

The blog can be read here: https://www.schroders.com/en-gb/uk/individual/content/spotting-the-red-flags-the-biotech-risks-we-avoid/

 

To sign up for IBT updates by email, please click here.

 

 

ENDS

 

 

Enquiries:

 

Schroder Investment Management Limited
Charlotte Banks (Press)
Kirsty Preston
Kerry Higgins (Company Secretary)
020 7658 6000
020 7658 6000
Kaso Legg Communications (Financial PR)
Charles Gorman
Henry Taylor
Effie Aye Maung Hider
IBT@kl-communications.com
          This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.   END     NRAXXLFLEELZBBL

Recent news on International Biotechnology Trust

See all news